Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2008-004740-36-GB
EUCTR2008-004740-36-GB
Active, not recruiting
Phase 1

Melatonin As A Novel Neuroprotectant In Preterm Infants-Trial Study - MINT- Melatonin Neuroprotection Trial Study -Ver 1

Imperial College, London0 sites60 target enrollmentMay 26, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBrain injury from prematurityMedDRA version: 14.0 Level: LLT Classification code 10013384 Term: Disorders relating to short gestation and unspecified low birthweight System Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditions

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Brain injury from prematurity
Sponsor
Imperial College, London
Enrollment
60
Status
Active, not recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 26, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Inclusion Criteria: Infants born less than 31 weeks gestation who are less than 48 hours old, after parental consent for participation will be included in the study.
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) no
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Exclusion Criteria: \-Infants born greater than or equal to 31 weeks gestation or more than 48 hours of age \-Infants with major congenital malformation \-Infants with cystic periventricular leucomalacia or haemorrhagic parenchymal infarction on cranial ultrasonography prior to enrolment will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Melatonin As A Novel Neuroprotectant in Preterm Infants- Dosage study - MIND-Melatonin Neuroprotection Dosage Study
EUCTR2007-007156-33-GBImperial College18
Completed
Phase 2
MIND: Melatonin Neuroprotection Dosage StudyTopic: Medicines for Children Research NetworkSubtopic: All DiagnosesDisease: All DiseasesInjury, Occupational Diseases, PoisoningBrain injury
ISRCTN01115788Imperial College London (UK)24
Completed
Phase 2
Melatonin as a novel neuroprotectant in preterm infants - trial studyBrain injury in premature babiesNeonatal DiseasesUnspecified brain damage due to birth injury
ISRCTN15119574Imperial College London (UK)60
Completed
Phase 2
Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage StudyPremature BirthBrain Injury
NCT00649961Imperial College London18
Completed
Not Applicable
Oral Melatonin as Neuroprotectant in Preterm InfantsMalondialdehydeMelatonin
NCT04235673Francesca Garofoli60